Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies M Alenquer, F Ferreira, D Lousa, M Valério, M Medina-Lopes, ... PLoS pathogens 17 (8), e1009772, 2021 | 97 | 2021 |
SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility M Valério, L Borges-Araújo, MN Melo, D Lousa, CM Soares Frontiers in medical technology 4, 1009451, 2022 | 20 | 2022 |
Parainfluenza fusion peptide promotes membrane fusion by assembling into oligomeric porelike structures M Valério, DA Mendonça, J Morais, CC Buga, CH Cruz, MARB Castanho, ... ACS Chemical Biology 17 (7), 1831-1843, 2022 | 10 | 2022 |
Assessing the Martini 3 protein model: A review of its path and potential L Borges-Araújo, GP Pereira, M Valério, PCT Souza Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 141014, 2024 | 9 | 2024 |
Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 binding M Alenquer, F Ferreira, D Lousa, M Valério, M Medina-Lopes, ... bioRxiv, 2021.04. 22.441007, 2021 | 7 | 2021 |
Martini 3 building blocks for Lipid Nanoparticle design LR Kjølbye, M Valério, M Paloncýová, L Borges-Araújo, ... | 5 | 2024 |
CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function C Pires, IJ Marques, M Valério, A Saramago, PE Santo, S Santos, M Silva, ... Journal of Biological Chemistry 300 (3), 2024 | 2 | 2024 |
Viral entry mechanisms: the role of molecular simulation in unlocking a key step in viral infections M Valério, CC Buga, MN Melo, CM Soares, D Lousa FEBS Open Bio 15 (2), 269-284, 2025 | 1 | 2025 |
Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery M Paloncýová, M Valério, RN Dos Santos, P Kührová, M Šrejber, ... Molecular Pharmaceutics, 2025 | | 2025 |
Design, Production and Characterization of Antiviral Proteins Targeting SARS-CoV-2 S Parreiras, CH Cruz, M Valerio, PMF Sousa, CM Soares, JB Vicente, ... FEBS OPEN BIO 12, 160-160, 2022 | | 2022 |
The impact of SARS-CoV-2 Omicron variant on the human ACE2 binding: a computational study R Teixeira, M Valerio, L Borges-Araujo, MN Melo, JB Vicente, D Lousa, ... FEBS OPEN BIO 12, 260-261, 2022 | | 2022 |
Together we fuse: parainfluenza virus fusion peptides oligomerize to promote membrane fusion M Valerio, D Mendonca, JM Morais, CC Buga, CH Cruz, M Castanho, ... FEBS OPEN BIO 12, 266-266, 2022 | | 2022 |
Molecular determinants of the SARS-CoV-2 fusion peptide activity CC Buga, M Valério, A Balola, AS Ferreira, AMFT Sequeira, M Rocha, ... | | 2021 |
PC3–Carolina C. Buga CC Buga, M Valério, DA Mendonça, JB Vicente, MARB Castanho, ... 3D-BIOINFO-PT, 37, 0 | | |